Effect of various adrenergic receptor stimulating and blocking agents on human growth hormone secretion.
D000293:Adolescent; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000328:Adult; D000628:Aminophylline / Q000494:pharmacology; D001786:Blood Glucose / Q000032:analysis; D004295:Dihydroxyphenylalanine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D005947:Glucose / Q000494:pharmacology; D013006:Growth Hormone / Q000097:blood / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012636:Secretory Rate / Q000187:drug effects; D013268:Stimulation, Chemical; D014439:Tyramine / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose; D010656:Phenylephrine; D000628:Aminophylline; D004295:Dihydroxyphenylalanine; D013006:Growth Hormone; D011433:Propranolol; D005947:Glucose; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine; D010646:Phentolamine